COVID Delays Leave Nearly 2,000 Drug Plants Behind on Inspections: Report
The FDA has been backlogged in drug factory inspections since before the COVID-19 pandemic, a new report found.
The FDA has been backlogged in drug factory inspections since before the COVID-19 pandemic, a new report found.